Scutellarin protects against Aβ-induced learning and memory deficits in rats: Involvement of nicotinic acetylcholine receptors and cholinesterase

Acta Pharmacologica Sinica

Volumn 32, Issue 12, 2011, Pages 1446-1453

  Guo, Li Li ^a   Guan, Zhi Zhong ^a   Wang, Yong Lin ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

amyloid peptide; cholinesterase; learning and memory; nicotinic acetylcholine receptor; piracetam; scutellarin

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; BUNGAROTOXIN RECEPTOR; CHOLINESTERASE; MESSENGER RNA; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; PIRACETAM; SCUTELLARIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; LEARNING; LEARNING DISORDER; MALE; MAZE TEST; MEMORY; NEUROPROTECTION; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANIMALS; APIGENIN; BASE SEQUENCE; BLOTTING, WESTERN; BUTYRYLCHOLINESTERASE; CHOLINESTERASES; DNA PRIMERS; GLUCURONIC ACIDS; INJECTIONS, INTRAVENTRICULAR; LEARNING DISORDERS; MALE; MEMORY DISORDERS; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC;

EID: 82955225089     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.115     Document Type: Article

References (52)

1. Zhu JT, Choi RC, Li J, Xie HQ, Bi CW, Cheung AW, et al. Estrogenic and neuroprotective properties of scutellarin from erigeron breviscapus: a drug against postmenopausal symptoms and Alzheimer's disease. Planta Med 2009; 75: 1489-93.
2. Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 1993; 44: 37-43. (Pubitemid 23230457)
3. Zhu JT, Choi RC, Chu GK, Cheung AW, Gao QT, Li J, et al. Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing beta-amyloid-induced cell death. J Agric Food Chem 2007; 55: 2438-45. (Pubitemid 46556236)
4. Wang CN, Chi CW, Lin YL, Chen CF, Shiao YJ. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem 2001; 276: 5287-95.
5. Kim H, Park BS, Lee KG, Choi CY, Jang SS, Kim YH, et al. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 2005; 53: 8537-41. (Pubitemid 41608910)
6. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000; 54: 295-301. (Pubitemid 30078056)
7. Zhang HF, Hu XM, Wang LX, Xu SQ, Zeng FD. Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway. Planta Med 2009; 75: 121-6.
8. Lin LL, Liu AJ, Yu XH, Qin LP, Su DF. Protective effects of scutellarin and breviscapine on brain and heart ischemia in rat. J Cardiovasc Pharmacol 2005; 50: 327-32.
9. Barrantes FJ, Borroni V, Vallés S. Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease. FEBS Lett 2010; 584: 1856-63.
10. Bayer TA, Wirths O. Intracellular accumulation of amyloid-beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front Aging Neurosci 2010; 10: 2-8.
11. Guglielmotto M, Giliberto L, Tamagno E, Tabaton M. Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. Front Aging Neurosci 2010; 9: 2-3.
12. Kubo T, Nishimura S, Kumagae Y, Kaneko I. In vivo conversion of racemized beta-amyloid ([D-Ser 26] A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J Neurosci Res 2002; 70: 474-83. (Pubitemid 35222384)
13. Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 1999; 22: 273-80. (Pubitemid 29259995)
14. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 2004; 11: 43-9. (Pubitemid 38167057)
15. Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 2000; 61: 75-111. (Pubitemid 30100404)
16. Lippiello P, Letchworth SR, Gatto GJ, Traina VM, Bencherif M. Ispronicline: a novel alpha4beta2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties. J Mol Neurosci 2006; 30: 19-20. (Pubitemid 46035302)
17. Viegas C Jr, Bolzani Vda S, Barreiro EJ, Fraga CA. New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors. Mini Rev Med Chem 2005; 5: 915-26. (Pubitemid 41300738)
18. Kamal MA, Qu X, Yu QS, Tweedie D, Holloway HW, Li Y, et al. Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis. J Neural Transm 2008; 115: 889-98.
19. Zhao B, Yang HJ, Zhao J. Development of an assay for screening betaamyloid aggregation inhibitors in vitro and study on inhibitive activity of fridelin. Chin Pharm J 2005; 40: 1474-7. (Pubitemid 43033051)
20. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1982.
21. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60. (Pubitemid 14088970)
22. Liu RY, Gu R, Qi XL, Tang Z, Zhao Y, He Y, et al. Decreased nicotinic receptors and cognitive deficit in rats intracerebroventricularly injected with beta-amyloid peptide(1-42) and fed a high-cholesterol diet. J Neurosci Res 2008; 86: 183-93.
23. An Y, Qi XL, Pei JJ, Tang Z, Xiao Y, Guan ZZ. Amyloid precursor protein gene mutated at Swedish 670/671 sites in vitro induces changed expression of nicotinic acetylcholine receptors and neurotoxicity. Neurochem Int 2010; 57: 647-54.
24. Ellman G, Courtney D, Andres V, Feather RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
25. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, et al. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a] pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. J Pharmacol Exp Ther 2006; 317: 1079-87.
26. Mazzola C, Micale V, Drago F. Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol 2003; 477: 219-25. (Pubitemid 38366394)
27. Wang CN, Chi CW, Lin YL, Chen CF, Shiao YJ. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem 2001; 276: 5287-95.
28. Jhoo JH, Kim HC, Nabeshima T, Yamada K, Shin EJ, Jhoo WK, et al. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res 2004; 155: 185-96. (Pubitemid 39208900)
29. Guan ZZ, Miao H, Tian JY, Unger C, Nordberg A, Zhang X. Suppressed expression of nicotinic acetylcholine receptors by nanomolar? Amyloid peptides in PC12 cells. J Neural Transm 2001; 108: 1417-33. (Pubitemid 34020446)
30. Steven DB, Andrew KJ, Laurence AB, David BS. Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 2009; 61: 39-61.
31. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 2007; 47: 699-729.
32. Lindstrom JM. Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci 2003; 998: 41-52. (Pubitemid 37194146)
33. Guan ZZ, Zhang X, Ravid R, Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 2000; 74: 237-43. (Pubitemid 30012774)
34. Guan ZZ, Nordberg A, Mousavi M, Rinne JO, Hellström-Lindahl E. Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease. Brain Res 2002; 956: 358-66. (Pubitemid 35351403)
35. Court J, Martin-Ruiz C, Piggott M. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 2001; 49: 175-84. (Pubitemid 32178426)
36. Kihara T, Shimohama S. Alzheimer's disease and acetylcholine receptors. Acta Neurobiol Exp 2004; 64: 99-105.
37. Patocka J, Kuca K, Jun D. Acetylcholinesterase and butyrylcholinesterase- important enzymes of human body. Acta Medica (Hradec Kralove) 2004; 47: 215-28.
38. Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging 2003; 24: 777-87. (Pubitemid 37288853)
39. Geula C, Darvesh S. Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease. Drugs Today (Barc) 2004; 40: 711-21. (Pubitemid 39281173)
40. Zhang LJ, Xiao Y, Qi XL, Shan KR, Pei JJ, Kuang SX, et al. Cholinesterase activity and mRNA level of nicotinic acetylcholine receptors (alpha4 and beta2 Subunits) in blood of elderly Chinese diagnosed as Alzheimer's disease. J Alzheimers Dis 2010; 19: 849-58.
41. Mesulam MM, Asuncion Morán M. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease. Ann Neurol 1987; 22: 223-8.
42. Ulrich J, Meier-Ruge W, Probst A, Meier E, Ipsen S. Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol 1990; 80: 624-8. (Pubitemid 20342503)
43. Melnikova I. Therapies for Alzheimer's disease. Nat Rev Drug Discov 2007; 6: 341-2.
44. Howes MJ, Houghton PJ. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 2003; 75: 513-27. (Pubitemid 36939171)
45. Liu JX, Liu Y, Chen XL, Zhao JJ, Song TS, Qian YH. Breviscapine improves functions of spatial learning and memory of focal cerebral ischemia rats. Zhong Yao Cai (Chinese) 2009; 32: 548-56.
46. Xiong Z, Liu C, Wang F, Li C, Wang W, Wang J, et al. Protective effects of breviscapine on ischemic vascular dementia in rats. Biol Pharm Bull 2006; 29: 1880-5. (Pubitemid 44338411)
47. Liu H, Yang XL, Zhou LZ, Xu HB. Study on reactive oxygen species scavenging effects of scutellarin. J Chin Med Mat 2002; 25: 491-3.
48. Liu H, Yang XL, Wang Y, Tang XQ, Jiang DY, Xu HB. Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes. Acta Pharmacol Sin 2003; 24: 1113-7.
49. Xu W, Zha RP, Wang WY, Wang YP. Effects of scutellarin on PKC in PC12 cell injury induced by oxygen and glucose deprivation. Acta Pharmacol Sin 2007; 28: 1573-9. (Pubitemid 47493275)
50. Hong H, Liu GQ. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci 2004; 74: 2959-73. (Pubitemid 38402293)
51. Croisile B, Trillet M, Fondarai J, Laurent B, Mauguière F, Billardon M. Long-term and high-dose piracetam treatment of Alzheimer's disease. Neurology 1993; 43: 301-5. (Pubitemid 23060259)
52. Bering B, Muller WE. Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Arzneim Forsch 1985; 35: 1350-2.